12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. Altamira Therapeutics (CYTO) saw a massive increase of 222.5%, while Fortress Biotech (FBIO) and Kodiak Sciences (KOD) also posted substantial gains following their recent earnings reports. Twist Bioscience (TWST) shares rose after their Q4 earnings release. Conversely, Vigil Neuroscience (VIGL), Bone Biologics (BBLG), Evelo Biosciences (EVLO), Aclarion (ACON), Tenax Therapeutics (TENX), and Solid Biosciences (SLDB) all saw their stock prices fall, with some also having released their Q3 earnings recently.
November 17, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Altamira Therapeutics stock soared by 222.5% with a trading volume surge, indicating strong investor interest.
The dramatic increase in stock price and trading volume suggests positive investor sentiment, which could lead to continued short-term momentum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Fortress Biotech's stock rose by 46.85% possibly related to its Q3 earnings report released three days ago.
The recent Q3 earnings report could be driving the stock's performance, suggesting a positive market reaction to the company's financials.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Kodiak Sciences shares increased by 27.64% following its Q3 earnings release three days ago.
The positive movement in stock price post-earnings suggests that the earnings report was well-received by investors.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Twist Bioscience's stock increased by 26.27% on the day of its Q4 earnings release.
The stock's rise on the day of its Q4 earnings announcement suggests the market's positive reception of the company's financial performance.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Aclarion's shares dropped by 20.0%, potentially in response to its Q3 earnings report.
The stock price decrease following the Q3 earnings release may reflect investor disappointment with the company's financial performance.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Bone Biologics experienced a 32.85% decrease in stock price, potentially related to its Q3 earnings report.
The decline in stock price shortly after the Q3 earnings release suggests the market may have reacted negatively to the company's financial results.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Evelo Biosciences' stock price decreased by 21.06%, with trading volume exceeding average levels.
The stock's decline, along with increased trading volume, may indicate a negative investor response to recent company news or market conditions.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Solid Biosciences' stock price fell by 16.18%, with trading volume around its average.
The stock's decline may be a reaction to broader market trends or specific company challenges, as indicated by the trading volume.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Tenax Therapeutics' stock declined by 18.46%, with a notable volume of trading.
The decrease in stock price, accompanied by a relatively high trading volume, could indicate a lack of confidence from investors.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Vigil Neuroscience's shares fell by 36.4%, with a significant increase in trading volume.
The substantial decline in stock price, coupled with increased trading volume, may reflect negative investor sentiment or reactions to recent company developments.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90